Showing results (441-450 of 830) with videos related to

Sort By:
Pageof 83
Pharmacogenetics|July 1, 2004
Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variantsElke Schaeffeler, Christine Fischer, Dierk Brockmeier, et al.
Pharmacogenetics|July 1, 2004
High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)Mikko Niemi, Elke Schaeffeler, Thomas Lang, et al.
Pharmacogenetics|July 1, 2004
Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8)Katrin Letschert, Dietrich Keppler, Jörg König
Pharmacogenetics|May 29, 2004
Differential transcriptional expresión of the polymorphic myxovirus resistance protein A in response to interferon-alpha treatmentNieves Fernández-Arcás, Asunción Blanco, M Jesús Gaitán, et al.
Pharmacogenetics|February 18, 1999
Use of heterologously expressed human cytochrome P450 1A2 to predict tacrine-fluvoxamine drug interaction in manL Becquemont, M A Le Bot, C Riche, et al.
Pharmacogenetics|December 11, 1999
Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variantsV Jovanovic, H C Guan, H H Van Tol
Pharmacogenetics|December 11, 1999
High and variable frequencies of CYP2C19 mutations: medical consequences of poor drug metabolism in Vanuatu and other Pacific islandsA Kaneko, J K Lum, L Yaviong, et al.
Pharmacogenetics|December 11, 1999
Genetic polymorphism of CYP2D6 in the Japanese populationM Chida, T Yokoi, Y Kosaka, et al.
Pharmacogenetics|December 11, 1999
N-acetyltransferase-2 polymorphism, smoking and type 1 diabetic nephropathyE Korpinen, P H Groop, A Rautio, et al.
Pharmacogenetics|December 11, 1999
Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A, TPMT*3B or TPMT*3CH L Tai, M Y Fessing, E J Bonten, et al.
Pageof 83